Trial Profile
Phase II Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Creatine monohydrate (Primary) ; Minocycline (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 11 Dec 2007 Status changed from in progress to completed.
- 23 Jul 2007 The expected completion date for this trial is now 1 Mar 2008.
- 18 Oct 2006 Status changed from recruiting to in progress.